36-2515. Substances in schedule IV

A. The following controlled substances are, unless specifically excepted, included in schedule IV:

1. Any material, compound, mixture or preparation that contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system, including its salts, isomers, whether optical, position or geometric, and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(a) Cathine (+(4)-norpseudoephedrine).

(b) Diethylpropion.

(c) Fencamfamin.

(d) Fenproporex.

(e) Mazindol.

(f) Mefenorex.

(g) Pemoline (including organometallic complexes and chelates thereof).

(h) Phentermine.

(i) Pipradrol.

(j) SPA((-)-1-dimethylamino-1, 2-diphenylethane).

(k) Butorphanol.

(l) Modafinil.

(m) Sibutramine.

2. Any material, compound, mixture or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(a) Alprazolam.

(b) Barbital.

(c) Bromazepam.

(d) Camazepam.

(e) Chloral betaine.

(f) Chloral hydrate.

(g) Chlordiazepoxide.

(h) Clobazam.

(i) Clonazepam.

(j) Chlorazepate.

(k) Clotiazepam.

(l) Cloxazolam.

(m) Delorazepam.

(n) Diazepam.

(o) Dichloralphenazone.

(p) Estazolam.

(q) Ethchlorvynol.

(r) Ethinamate.

(s) Ethyl loflazepate.

(t) Fludiazepam.

(u) Flunitrazepam.

(v) Flurazepam.

(w) Halazepam.

(x) Haloxazolam.

(y) Ketazolam.

(z) Loprazolam.

(aa) Lorazepam.

(bb) Lormetazepam.

(cc) Mebutamate.

(dd) Medazepam.

(ee) Meprobamate.

(ff) Methohexital.

(gg) Methylphenobarbital (methobarbital).

(hh) Midazolam.

(ii) Nimetazepam.

(jj) Nitrazepam.

(kk) Nordiazepam.

(ll) Oxazepam.

(mm) Oxazolam.

(nn) Paraldehyde.

(oo) Petrichloral.

(pp) Phenobarbital.

(qq) Pinazepam.

(rr) Prazepam.

(ss) Quazepam.

(tt) Temazepam.

(uu) Tetrazepam.

(vv) Triazolam.

(ww) Zaleplon.

(xx) Zolpidem.

3. Fenfluramine.

4. Any material, compound, mixture or preparation containing any of the following narcotic drugs, or their salts, calculated as the free anhydrous base or alkaloid, in limited quantities of not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit.

5. Any material, compound, mixture or preparation that contains any quantity of the following substances, including its salts:

(a) Carisoprodol.

(b) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl- 3-methyl-2-propionoxybutane).

(c) Pentazocine.

B. The board may except by rule any compound, mixture or preparation containing any substance listed in this section from the application of all or any part of this chapter if the compound, mixture or preparation contains one or more active medicinal ingredients and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiates the potential for abuse.

36-2515. Substances in schedule IV

A. The following controlled substances are, unless specifically excepted, included in schedule IV:

1. Any material, compound, mixture or preparation that contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system, including its salts, isomers, whether optical, position or geometric, and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(a) Cathine (+(4)-norpseudoephedrine).

(b) Diethylpropion.

(c) Fencamfamin.

(d) Fenproporex.

(e) Mazindol.

(f) Mefenorex.

(g) Pemoline (including organometallic complexes and chelates thereof).

(h) Phentermine.

(i) Pipradrol.

(j) SPA((-)-1-dimethylamino-1, 2-diphenylethane).

(k) Butorphanol.

(l) Modafinil.

(m) Sibutramine.

2. Any material, compound, mixture or preparation that contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(a) Alprazolam.

(b) Barbital.

(c) Bromazepam.

(d) Camazepam.

(e) Chloral betaine.

(f) Chloral hydrate.

(g) Chlordiazepoxide.

(h) Clobazam.

(i) Clonazepam.

(j) Chlorazepate.

(k) Clotiazepam.

(l) Cloxazolam.

(m) Delorazepam.

(n) Diazepam.

(o) Dichloralphenazone.

(p) Estazolam.

(q) Ethchlorvynol.

(r) Ethinamate.

(s) Ethyl loflazepate.

(t) Fludiazepam.

(u) Flunitrazepam.

(v) Flurazepam.

(w) Halazepam.

(x) Haloxazolam.

(y) Ketazolam.

(z) Loprazolam.

(aa) Lorazepam.

(bb) Lormetazepam.

(cc) Mebutamate.

(dd) Medazepam.

(ee) Meprobamate.

(ff) Methohexital.

(gg) Methylphenobarbital (methobarbital).

(hh) Midazolam.

(ii) Nimetazepam.

(jj) Nitrazepam.

(kk) Nordiazepam.

(ll) Oxazepam.

(mm) Oxazolam.

(nn) Paraldehyde.

(oo) Petrichloral.

(pp) Phenobarbital.

(qq) Pinazepam.

(rr) Prazepam.

(ss) Quazepam.

(tt) Temazepam.

(uu) Tetrazepam.

(vv) Triazolam.

(ww) Zaleplon.

(xx) Zolpidem.

3. Fenfluramine.

4. Any material, compound, mixture or preparation containing any of the following narcotic drugs, or their salts, calculated as the free anhydrous base or alkaloid, in limited quantities of not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit.

5. Any material, compound, mixture or preparation that contains any quantity of the following substances, including its salts:

(a) Carisoprodol.

(b) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl- 3-methyl-2-propionoxybutane).

(c) Pentazocine.

B. The board may except by rule any compound, mixture or preparation containing any substance listed in this section from the application of all or any part of this chapter if the compound, mixture or preparation contains one or more active medicinal ingredients and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiates the potential for abuse.